Planinski čaj za čišćenje
| Name | Planinski čaj za čišćenje |
|---|---|
| Marketing Authorisation Number | HR-H-562622244 |
| Active Substance | senin list krkavinina kora kamiličin cvijet plod gorkoga komorača borovičina smrekinja list paprene metvice kimov plod |
| Composition | 1 g biljnog čaja sadrži 0,400 g senina lista (Cassia senna L. (C. acutifolia Delile) i/ili C. angustifolia Vahl, folium) što odgovara 10 do 12 mg hidroksiantracenskih glikozida, izračunano kao senozid B 0,200 g krkavinine kore (Rhamnus frangula L. (Frangula alnus Miller, cortex), što odgovara 14 do 24 mg glukofrangulina, izraženo kao glukofrangulin A 0,150 g kamiličina cvijeta (Matricaria recutita L. (Chamomilla recutita (L.) Rauschert), flos) 0,075 g ploda gorkoga komorača (Foeniculum vulgare Miller sp. vulgare var. vulgare, fructus) 0,075 g borovičinih smrekinja (Juniperus communis L., Juniperi galbulus) 0,050 g lista paprene metvice (Mentha x piperita L., folium) 0,050 g kimova ploda (Carum carvi L., fructus) |
| Pharmaceutical Form | biljni čaj |
| Manufacturer | Trešnjevka laboratorij d.o.o., Zagreb, Republika Hrvatska |
| Marketing Authorisation Holder | Trešnjevka laboratorij d.o.o., Jukićeva 32, Zagreb |
| Marketing Authorisation Date | 23.08.2017 |
| MA Period of Validity | unlimited |
| MA Revocation Date | 14.02.2024* |
| Classification Number | UP/I-530-09/16-02/507 |
| Registration Number | 381-12-01/38-17-09 |
| Prescription | bez recepta |
| Distribution | u ljekarni |
| Advertising to general public | dopušteno |
| ATC Code | A06AB |
| Medicinal product marketed in the Croatia | Trajni prekid opskrbe |
| SmPC | download |
| PL | download |
*Note
Marketing authorisation has been revoked by request of the marketing authorisation holder. In accordance with Article 113 of Medicinal Products Act (Official Gazette No. 76/13), only a medicinal product in respect of which a marketing authorisation has been granted by the Agency for Medicinal Products and Medical Devices or the European Commision, and a medicinal product in respect of which an authorisation for parallel import or parallel distribution has been granted may be placed on the market of the Republic of Croatia. By way of derogation from this provision, a batch of medicinal product may be on the market for no longer than 18 months following the expiry of revocation of the marketing authorisation, unless its shelf life expires first.
